SCHEMBL30695014

SCHEMBL30695014

O=CCCC(=O)C(=O)c1ccccn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.58
CES1 P23141 1/20 0.58
LMNA P02545 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
NAPRT Q6XQN6 1/20 0.47
P4HTM Q9NXG6 1/20 0.47
ALDH1A1 P00352 2/20 0.46
HDAC1 Q13547 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
KMT2A Q03164 2/20 0.43
GPR52 Q9Y2T5 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 3/20 0.42
MAPT P10636 2/20 0.42
HTT P42858 1/20 0.42
GSK3B P49841 1/20 0.42
CTNNB1 P35222 3/20 0.42
WNT3A P56704 2/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9747177 0.83 CTNNB1 (0.55) CES2CES1LMNAL3MBTL1NAPRT
SCHEMBL19287209 0.77 CTNNB1 (0.53) CES2CES1LMNAL3MBTL1NAPRT
SCHEMBL29466796 0.75 CES2 (1.00) CES2CES1LMNAL3MBTL1NAPRT
SCHEMBL29466797 0.75 CES2 (1.00) CES2CES1LMNAL3MBTL1NAPRT
SCHEMBL211487 0.75 CES2 (1.00) CES2CES1LMNAL3MBTL1NAPRT
SCHEMBL27621482 0.73 CES2 (0.69) CES2CES1LMNAL3MBTL1NAPRT
SCHEMBL31249613 0.72 CES2 (0.62) CES2CES1LMNAL3MBTL1NAPRT
SCHEMBL29976899 0.72 CES2 (0.82) CES2CES1LMNAL3MBTL1NAPRT
SCHEMBL225566 0.72 CES2 (0.55) CES2CES1LMNAL3MBTL1NAPRT
2-Picolinic Acid SCHEMBL444767 0.70 CES2 (0.64) CES2CES1LMNAL3MBTL1NAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117500802-A LACTIVICIN compounds, their preparation and their use as antibacterial agents 费多拉制药有限公司 2024-02-02 CN disclosed